P2Y12 receptor inhibitors in ACS

22 Jul

The cornerstone of treatment of ACS in the ED is aspirin, anticoagulation and P2Y12 receptor inhibitors. It is in the guidelines, but still it is interesting to look at the evidence behind the guidelines! Just read the article in BMJ called: “Why we can’t trust clinical guidelineshttp://www.bmj.com/content/346/bmj.f3830.

Today we dive into the evidence of  P2Y12 receptor inhibitors for ACS. The ones we look at are clopidogrel, prasugrel and ticagrelor! And just so you know, I have no conflict  of interest!!!

Here is the table with the articles:

Table P2Y12


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s